13th Edition · Global Conference on Pharmaceutics and Novel Drug Delivery Systems 2026

September 14–16, 2026 · Rome, Italy

47Speakers
51Presentations
23Countries

About PDDS 2026

The 13th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems was successfully concluded from September 14–16, 2026, in Rome, Italy. The event brought together researchers, academicians, pharmaceutical scientists, healthcare professionals, and industry experts to share their latest research findings, innovations, and advancements in pharmaceutics and drug delivery technologies. The event provided a valuable platform for scientific discussions, knowledge exchange, and collaboration on emerging drug delivery systems, pharmaceutical formulations, and innovative therapeutic approaches.

The successful conclusion of the event marked an important step toward encouraging scientific innovation and strengthening global collaboration in pharmaceutical research and development. We sincerely thank all the speakers, delegates, participants, and organizing committee members for their valuable contributions and support in making the event a success. We look forward to continued collaboration and welcoming everyone to future editions.

Scientific Program

Day 113 presentations

  1. Non-crystalline stabilization of iron-oxide nanoparticles enables a versatile platform for carrier-dependent and carrier-free drug delivery

    Lan Wang · Paretor LLC

  2. Azobenzene-enriched PEG-PLGA micelles as a light-responsive drug delivery platform: Effect of light on biological activity

    Mila Radan · University of Split

  3. Tailored cellular environments to enable drug design

    Lan Wang · Paretor LLC

  4. Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle

    Lucas Amaral Machado · University of Sao Paulo State – UNESP

  5. Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona

  6. An injectable CarboCell depot technology for local, sustained dual-antibiotic delivery in bone infections

    Niranjan G Kotla · Technical University of Denmark (DTU)

  7. Novel fabrication of adaptive transdermal technologies for drug delivery

    Zeeshan Ahmad · University of Manchester

  8. Rational optimization of antibody–cyanine bioconjugates for targeted theranostic drug delivery and photo/sono activation

    Amartya Sanyal · Ariel University

  9. Design and characterization of gum arabic buccal films for protein drug delivery

    Krisztian Pamlenyi · University of Szeged

  10. Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties

    Lan Wang · Paretor LLC

  11. Design and optimization of a nanotechnological platform for future delivery of Sarcomphalus joazeiro (Mart.) extract in dental bleaching

    Lucas Amaral Machado · University of Sao Paulo State – UNESP

  12. Antibody proteases as translational tools of the next step generation to be applied for biopharmacy related and precision medical practice

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona

  13. Structure-based discovery of kinetic stabilizers for transthyretin amyloidosis

    Salvador Ventura · Universitat Autònoma de Barcelona

Day 221 presentations

  1. From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer

    Vladlen Slepak · University of Miami School of Medicine

  2. Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems

    Bernd Blobel · University of Regensburg

  3. Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications

    Axel H Schonthal · University of Southern California

  4. Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry

    Maria Cristina Gamberini · University of Modena and Reggio Emilia

  5. Hepatotoxic botanicals-shadows of pearls

    Consolato M Sergi · University of Alberta

  6. The impact of metal-decorated polymeric nanodots on proton relaxivity

    Paulo Cesar De Morais · Catholic University of Brasilia

  7. Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers

    Huiqin Yang · ICON Clinical Research Ltd

  8. Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials

    Luis Jesus Villarreal Gomez · Universidad Autónoma de Baja California

  9. Development and characterization of dual-functional nanofibrous dressing system for burn wound management

    Adrienn Nochta Kazsoki · Semmelweis University

  10. Diabetes risk stratification using self-reported health indicators: A machine learning and explainability approach

    Tanuja Tummala · Harrisburg University of Science and Technology

  11. Cognitivevoice: Novel machine learning model leveraging acoustic features to predict future cognitive decline in Parkinson’s Disease

    Aadya Daga · Hamilton High School

  12. R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators

    Adriana Gambardella · Medicine Discovery Catapult

  13. Characterization, antibacterial, and cytotoxic activities of silver nanoparticles using the whole biofilm layer as a macromolecule in biosynthesis

    Aghapy Yermans Yakoup · Zewail City for Science and Technology

  14. Polyphenols as pharmaceutical active ingredients: Current challenges in bioavailability and novel drug delivery

    Roman Lysiuk · Danylo Halytsky Lviv National Medical University

  15. GC-MS/FID analysis of tea tree oil and development of its nanostructured lipid carriers

    Cemre Irem Ayguler · Acıbadem Mehmet Ali Aydınlar University

  16. QSAR analysis in drug design: A retrospective, current state, and case studies of mapping structure–activity landscapes of thiazolopyridine-based APIs

    Olena Klenina · Danylo Halytsky Lviv National Medical University

  17. In silico investigation of thiazolo[4,5-b]pyridine derivatives as potential anti-inflammatory and antioxidant agents

    Olena Klenina · Danylo Halytsky Lviv National Medical University

  18. Infant exposure to cannabinoids via the mother’s milk

    Anna W Sobanska · Medical University of Lodz

  19. Evaluation of surface-charged donepezil-loaded liposomes for intranasal nose-to-brain drug delivery

    Elika Valehi · University of Szeged

  20. Platelet-activating factor-receptor pathway mediates solar radiation-induced extracellular vesicle release in human keratinocytes

    Ravi P Sahu · Wright State University

  21. Artificial Intelligence and digital twins in drug product development: Shaping the future of regulatory science

    Bhasker Sambar · Alvogen Inc

Day 317 presentations

  1. Hydrogen sulfide in sepsis: From bench to bedside

    Madhav Bhatia · University of Otago

  2. From nanoparticles to microneedles: Emerging strategies in skin cancer treatment

    Anil Pareek · Anand Pharmacy College

  3. From in silico docking to in vivo relevance: Predicting drug binding to ligand-bound human serum albumin

    Saad Tayyab · UCSI University

  4. Combinational in silico methods-based screening and selection of druggable targets in certain immune, non-immune and stromal cells in TNBC TME - Lessons for delivery of natural molecules with differentiation potential

    Suresh P.K · VIT University

  5. A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder

    Kunal Sharma · Swisss Federal Institute of Technology Lausanne

  6. From design to activity: Linker flexibility in 3-spiro-2-oxindoline VEGFR-2 inhibitors

    Tarek Aboul Fadl · Assiut University

  7. Development of a next-generation hepatocyte-targeted nucleic acid delivery platform evading LDLR dependence and PEG-related immunogenicity

    Helen Cho · Samyang Biopharm Corporation

  8. Exploring classical ayurvedic drugs in hypertension

    Prashant Sakharam Bhokardankar · Datta Meghe Ayurvedic Medical College Hospital and Research Centre

  9. Formulation, optimization, and in vitro characterization of chitosan–alginate polyelectrolyte complex microbeads incorporated into a natural hydrophilic matrix for extended oral delivery of an antihypertensive drug

    Rama Rao Nadendla · Chalapathi Institute of Pharmaceutical Sciences

  10. Development of liquid formulations of plasma proteins

    Bhupendra G Prajapati · Parul University

  11. Pharmaceutical contaminants in the environment: Risk assessment challenges and remediation approaches

    Neha Agarwal · Navyug Kanya Mahavidyalaya

  12. Structure-based design and smart formulation of stimuli-responsive nanocarriers: Bridging computational docking with advanced drug delivery for targeted therapeutics

    Pradeepa Prasad · The Oxford College of Pharmacy

  13. Cannabis therapeutic formulations: SWOT analysis

    Parikshit R Shirode · Parul University

  14. Formulation and development of herbal in-situ sustained release otic gel for the treatment of otitis media using Eclipta alba

    Dev Soni · Shree Swaminarayan Sanskar Pharmacy College

  15. Development of arteether nanoemulsion for improved oral bioavailability and antimalarial efficacy against Plasmodium yoelii nigeriensis

    Priyanka Chaturvedi · Jai Narain College of Pharmacy, JNCTPU

  16. Fabrication, characterization, and evaluation of pyrazinamide-loaded immediate-release tablets via fused deposition modeling 3D printing for personalized tuberculosis treatment

    Shubham Singh · Maharaja Ranjit Singh Punjab Technical University

  17. Nanotechnology in pharmaceutics and drug delivery systems: A medicinal mathematics perspective

    Vishwa Mehul Patel · Shri Swaminarayan Institute

View the full 2026 program →

Speakers

Huiqin Yang

Huiqin Yang

ICON Clinical Research Ltd · United Kingdom

Sergey Suchkov

Sergey Suchkov

N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona · Russian Federation

Tanuja Tummala

Tanuja Tummala

Harrisburg University of Science and Technology · United States

Kunal Sharma

Kunal Sharma

Swisss Federal Institute of Technology Lausanne · Switzerland

Mila Radan

Mila Radan

University of Split · Croatia (Hrvatska)

Helen Cho

Helen Cho

Samyang Biopharm Corporation · Korea, Republic of

Dev Soni

Dev Soni

Shree Swaminarayan Sanskar Pharmacy College · India

Shubham Singh

Shubham Singh

Maharaja Ranjit Singh Punjab Technical University · India

Roman Lysiuk

Roman Lysiuk

Danylo Halytsky Lviv National Medical University · Ukraine

Olena Klenina

Olena Klenina

Danylo Halytsky Lviv National Medical University · Ukraine

All 2026 speakers →

Scientific Committee

Huiqin Yang

Huiqin Yang

ICON Clinical Research Ltd · United Kingdom

Sergey Suchkov

Sergey Suchkov

N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona · Russian Federation

All 2026 committee members →

Gallery

All 27 photos from PDDS 2026 →

Downloads

14th Edition · PDDS 2027

September 13–15, 2027 · Olympia Hotel, Events & Spa, Valencia, Spain. Registration and abstract submission are open.

Register for PDDS 2027 →

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.